Back to Search Start Over

Immune Checkpoint Blockade plus Axitinib for Renal-Cell Carcinoma. Reply.

Authors :
Motzer RJ
Huang B
Source :
The New England journal of medicine [N Engl J Med] 2019 Jun 27; Vol. 380 (26), pp. 2581-2582.
Publication Year :
2019

Details

Language :
English
ISSN :
1533-4406
Volume :
380
Issue :
26
Database :
MEDLINE
Journal :
The New England journal of medicine
Publication Type :
Editorial & Opinion
Accession number :
31242370
Full Text :
https://doi.org/10.1056/NEJMc1905518